Jeffrey Ludwig
Fortuna: 773 832 $ al 30/06/2026
Fortuna: 773 832 $ al 30/06/2026
Jeffrey Ludwig worked at Amgen, Inc. from 2001 to 2019, serving as Vice President-Oncology Sales from 2014 to 2019.
Then worked at Astellas Pharma, Inc. from 2019 to 2020 as Vice President-Oncology Sales.
Education includes an undergraduate degree from Arizona State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,19 % | 13/04/2026 | 95.417 ( 0,19 % ) | 773 832 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 08/05/2025 |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01/03/2020 |
| AMGEN INC. | Corporate Officer/Principal | 01/08/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Puma Biotechnology, Inc.
Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.